By helping people maintain a healthier weight, semaglutide reduces some of the risks linked to obesity, like heart disease and diabetes
The second, for cardiovascular risk reduction in adults with obesity or overweight and established heart disease, arrived in March 2024
We know that craving predicts relapses in many cases, so having established that reduction, the next question is whether drugs like liraglutide suppress craving and relapse in the natural environment. Grigson and Bunce similarly emphasize the preliminary nature of their findings and the need for follow-up studies
Stopping GLP-1 medications suddenly can throw your body off balance, disrupting its ability to manage hormones and blood sugar effectively
While glutathione is naturally present in the body and plays important roles in fetal development, intentional supplementation with injectable forms has not been adequately studied to establish safety during pregnancy or breastfeeding